Agomelatine for the treatment of major depressive episodes (terminated appraisal)

  • Technology appraisal
  • TA231
  • Published: 
Download guidance (PDF)

Overview

NICE is unable to recommend the use in the NHS of agomelatine for the treatment of major depressive episodes. This is because Servier did not provide an evidence submission.

Last reviewed: 27 July 2011

Next review: We will review this decision if the company decides to make a submission.